Search Within

Emily A Miao

Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
  3. Correspondence (1)
  4. Editorial (1)
Groups
  1. Radiation Oncology, Department of (8)
  2. Epidemiology and Biostatistics (5)
  3. Multidisciplinary Brain Metastasis Program (5)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  5. Computational Oncology Service (4)
  6. Department of Medicine (4)

More Groups

People
  1. Luke Pike (8)
  2. Brandon Imber (6)
  3. Nelson Moss (5)
  4. Henry Walch (4)
  5. Jordan Eichholz (4)
  6. Nikolaus Schultz (4)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (3)
  4. 2022 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Neuro-Oncology (2)
  3. JTO Clinical and Research Reports (1)
  4. Lung Cancer (1)
  5. Translational Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Oxford University Press (2)
  3. Elsevier BV (1)
  4. Elsevier Ireland Ltd. (1)
  5. Pioneer Bioscience Publishing Company (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osimertinib-chemotherapy synergy in EGFR-mutant NSCLC: Advancing central nervous system control amidst toxicity considerations
    Editorial

    Kumar, R.; Miao, E.; Pike, L. R. G.
    Translational Cancer Research (2025)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC)
    Journal Article

    Pike, L. R. G.; Miao, E.; Boe, L. A.; Patil, T.; Imber, B. S.; Myall, N. J.; Pollom, E. L.; Hui, C.; Qu, V.; Langston, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases
    Meeting Abstract

    Khatri, I. S.; Eichholz, J.; Boe, L. A.; Safonov, A.; Smith, D. R.; Ferraro, E.; Shen, J.; Imber, B. S.; Yu, Y.; Yamada, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Improved CNS control with the addition of chemotherapy to osimertinib: A devil's bargain?
    Correspondence

    Yu, Y.; Miao, E.; Pike, L. R. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The genomic landscape of brain metastasis
    Meeting Abstract

    Skakodub, A.; Walch, H.; Kumar, R.; Eichholz, J.; Cooper, C.; Khatri, I.; Del Balzo, L.; Miao, E.; Gui, C.; Ma, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Intracranial outcomes of de novo brain metastases treated with osimertinib alone in patients with newly diagnosed EGFR-mutant NSCLC
    Journal Article

    Imber, B. S.; Sehgal, R.; Saganty, R.; Reiner, A. S.; Ilica, A. T.; Miao, E.; Li, B. T.; Riely, G. J.; Yu, H. A.; Panageas, K. S.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save